Paper
Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
Published Nov 1, 2017 · Nadhir Litim, M. Morissette, D. Caruso
The Journal of Steroid Biochemistry and Molecular Biology
18
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Non-RCTAnimal Study
Study Snapshot
Dutasteride shows potential as a neuroprotective drug in Parkinson's disease by enhancing testosterone levels and decreasing DHT levels in mice.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···